Hydroxyethyl starch-based infusion solutions withdrawn from market

Hydroxyethyl starch-based infusion solutions are being withdrawn from the pharmaceutical market for safety reasons.

Published 7sem1 source

≈ 16sSpeed

The fact

This decision follows concerns about risks associated with these injectable solutions.

Healthcare professionals must now use approved alternatives.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on May 31, 2026